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Background: H3N8 equine influenza virus (EIV) has caused disease outbreaks in horses across the world since its
first isolation in 1963. However, unlike human, swine and avian influenza, there is relatively little sequence data
available for this virus. The majority of published sequences are for the segment encoding haemagglutinin (HA),
one of the two surface glycoproteins, making it difficult to study the evolution of the other gene segments and
determine the level of reassortment occurring between sub-lineages.
Methods: To facilitate the generation of full genome sequences for EIV, we developed a simple, cost-effective and
efficient method. M13-tagged primers were used to amplify short, overlapping RT-PCR products, which were then
sequenced using Sanger dideoxynucleotide sequencing technology. We also modified a previously published
method, developed for human H3N2 and avian H5N1 influenza viruses, which was based on the ligation of viral
RNA and subsequent amplification by RT-PCR, to sequence the non-coding termini (NCRs). This necessitated the
design of novel primers for an N8 neuraminidase segment.
Results: Two field isolates were sequenced successfully, A/equine/Lincolnshire/1/07 and A/equine/Richmond/1/07,
representative of the Florida sublineage clades 1 and 2 respectively. A total of 26 PCR products varying in length
from 400–600 nucleotides allowed full coverage of the coding sequences of the eight segments, with sufficient
overlap to allow sequence assembly with no primer-derived sequences. Sequences were also determined for the
non-coding regions and revealed cytosine at nucleotide 4 in the polymerase segments. Analysis of EIV genomes
sequenced using these methods revealed a novel polymorphism in the PA-X protein in some isolates.
Conclusions: These methods can be used to determine the genome sequences of EIV, including the NCRs, from
both clade 1 and clade 2 of the Florida sublineage. Full genomes were covered efficiently using fewer PCR
products than previously reported methods for influenza A viruses, the techniques used are affordable and the
equipment required is available in most research laboratories. The adoption of these methods will hopefully allow
for an increase in the number of full genomes available for EIV, leading to improved surveillance and a better
understanding of EIV evolution.
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Equine influenza virus (EIV) is an influenza A virus
belonging to the Orthomyxoviridae family. These viruses
have a negative sense, single-stranded RNA genome
consisting of eight viral gene segments [1]. Originally
thought to have transmitted from birds, H3N8 EIV was
first isolated during a widespread outbreak in the United
States in 1963 [2], and has since spread worldwide caus-
ing multiple major outbreaks of disease in horses. Dur-
ing the 1980s the virus diverged into two antigenically
distinct lineages [3], American and Eurasian, and since
then the American lineage has further evolved into the
Florida sublineage clades 1 and 2, which continue to co-
circulate today [4]. These lineages have historically been
based on antigenic and genetic data for HA. A phylogen-
etic study by Murcia et al. [5] showed that phylogenetic
trees produced for each of the viral gene segments also
supported division into the American and Eurasian
lineages, and all but segment 7 divided into the two
clades of the Florida sublineage. However, less than 100
complete viral genomes covering the 46 years from 1963
to 2008 were available at the time of the study.
Other groups have studied the evolution of individual
influenza A virus genes. H3N8 EIV PB2 [6] and matrix
proteins [7] were found to belong to the same lineage as
North American avian strains, whilst PB1, PA, HA and
NP were found to have evolved independently from
other influenza A viruses [8-10]. Equine NS was sug-
gested as being restricted to subtype [11], as the NS seg-
ments of the H3N8 viruses were close to one another
but not to that of the H7N7 viruses, however very lim-
ited numbers of EIV genomes were available at the time
these studies were performed, and in some cases only
two different EIV strains were used. More recently a
study found that the internal genes of the 1963 EIV pan-
demic virus were of western hemispheric avian influenza
origin [12]. This study also showed that the virus shared
a most recent common ancestor with avian influenza vi-
ruses from South America shortly before its emergence.
The time to most recent common ancestor for avian/
equine NP was calculated as being 1954, which agreed
with the hypothesis that the virus emerged in South
America prior to its introduction into the USA in 1963
by horses imported by air from Argentina [12].
Following an extensive outbreak in 1989 affecting a
highly vaccinated population of racehorses in the UK, it be-
came clear that, like human influenza virus, EIV undergoes
antigenic drift and therefore vaccine strains need to be kept
up to date [13,14]. A formal process for vaccine strain se-
lection, overseen by the World Organisation for Animal
Health (OIE) was put in place. This process relies heavily
on surveillance data collected from the field, of which most
is focussed solely on the HA gene and the protein it en-
codes. Therefore the majority of published sequences arefor HA, which makes it difficult to study the evolution of
either the other gene segments or the virus as a whole. It is
also known that reassortment between the different line-
ages of EIV has occurred [4-8,15,16] but the full extent is
unknown due to a lack of data available. Avian H3N8 influ-
enza viruses have been shown to frequently exchange in-
ternal gene segments, and it has been suggested that the
extensive reassortment within the H3 subtype poses a
threat to human and animal health [17]. Next generation
sequencing technologies have made it easier to sequence
whole viral genomes, however these technologies are not
readily available to all as considerable investment in equip-
ment and bioinformatics expertise are needed. We aimed
to develop a simple and robust method to sequence whole
EIV genomes from all H3N8 lineages using Sanger dideoxy-
nucleotide sequencing technology.
Each of the eight influenza virus gene segments con-
tains two non-coding regions (NCRs), one at the 5′
terminus containing 13 conserved nucleotides, and the
other at the 3′ terminus, which contains 12 nucleotides
[18]. Unlike the 5′ end, the 3′ terminus exhibits vari-
ation at the fourth nucleotide. This variation in the
fourth nucleotide has been shown to affect the rescue of
virus from a reverse genetics system [19]. A second ob-
jective, to implement a method previously described for
sequencing the NCRs of influenza viruses [20], was
adapted and carried out on an EIV, as well as an N8 sub-
type neuraminidase, for the first time.
Here we describe the genome sequencing method and
highlight the sequence differences found between repre-
sentatives of the two circulating clades of the Florida
sublineage.
Results
Genome sequencing of equine influenza viruses
At the time of writing, only 81 full genome sets were
available from the NCBI Influenza Virus Resource for
EIV and only one or two gene segment sequences had
been published for the majority of strains. To address
the lack of available genomes, a method to sequence the ge-
nomes of equine influenza viruses belonging to both clades
of the currently circulating Florida sublineage, using an
EIV specific primer set for PCR and M13 primers for
sequencing, was developed. A/equine/Richmond/1/07
was selected as a representative of recent Florida sublineage
clade 2 (FC2) viruses, as well as being a current OIE recom-
mended vaccine strain. A/equine/Lincolnshire/1/07 was
chosen because it was the first virus belonging to clade 1 of
the Florida sublineage isolated in the UK [4]. Published
nucleotide sequences were aligned for each segment and
primers were designed to conserved regions (data not
shown) to amplify products of 400–600 nucleotides
(Figure 1). Each specific primer was elongated at the 5′ end
by adding either M13 forward or M13 reverse primer



















Figure 1 Schematic representation of PCR primer design for genome sequencing EIV. Primers were tagged with M13 forward or reverse
sequences for use in the sequencing stage. Segments 1–4 (PB2, PB1, PA and HA) were divided into four sections, segments 5 & 6 (NP and NA)
into three sections and segments 7 & 8 (M and NS) into two sections, each of approximately 400–600 nucleotides in length.
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cing swine influenza genomes [21] which facilitated effi-
cient sequencing. Four amplicons were produced for the
larger genome segments, 1 to 4, three amplicons for seg-
ments 5 and 6, and two amplicons for segments 7 and 8
(Figure 2). A total of 26 PCR products were amplified
successfully from RNA extracted from allantoic fluid for
both virus strains, A/equine/Richmond/1/07 and A/equine/
Lincolnshire/1/07. The nucleotide sequences of the PCR
products were determined on both strands and the com-
plete viral genome was assembled successfully without the
need for further specific primers to complete gaps. The
PCR products overlapped by approximately 100 nucleotides
at each end and sequences were edited, so that the final
coding sequence contained no primer-derived sequences.
This method has since been applied to a further 17 strains
of EIV, all primers worked well for Florida clade 1 and clade
2 strains from 2009–2013, and sequences were made avail-
able on the GISAID (Global Initiative on Sharing Avian In-
fluenza Data) EpiFlu database [22] (see Additional file 1).
Assembled sequences for each segment of A/equine/
Richmond/1/07 and A/equine/Lincolnshire/1/07 were also
uploaded onto GenBank, accession numbers indicated in
additional material (see Additional file 2).
The gene segment sequences for each of the two vi-
ruses were aligned against one another for comparison.There were a total of 279 nucleotide differences between
the two viruses, which resulted in 65 amino acid changes
(Table 2). Approximately 45% (29) of the total amino
acid changes were observed within the polymerase and
nucleoprotein segments, with 45% (13) of these occur-
ring within PA alone. The two glycoprotein segments,
HA and NA, contained 40% (26) of the total amino acid
differences, of which 54% (14) were within HA and 46%
(12) within NA.
The two smaller segments, M and NS, contained a
total of 10 amino acid changes within the four predicted
polypeptides (M1, M2, NS1 and NS2/NEP) that they
encode.
Nucleotide changes in three segments resulted in dif-
ferent lengths for their predicted polypeptides. A dupli-
cation of six nucleotides in A/equine/Richmond/1/07
resulted in a two amino acid insertion within the puta-
tive signal peptide of the precursor HA protein extend-
ing its length from 15 to 17 amino acids, as observed in
recent FC2 isolates [4]. In contrast, when compared to
earlier EIV isolates from 1963–2000 the predicted amino
acid sequences for the NS1 protein from both viruses
were truncated by 11 amino acids, as seen for other re-
cent isolates [4]. This was caused by a premature stop
codon at position 220, resulting in a predicted polypep-
tide length of 219 amino acids. The open reading frame
Table 1 Primer sequences and annealing temperatures used to sequence the genome of H3N8 EIV




PB2/AF GC GTAAAACGACGGCCAGT AGCGAAAGCAGGCAAATATATTCAATATG 1-655 50
PB2/AR GC AACAGCTATGACCATG CTCTTTCTAGCATGTAT
PB2/BF GC GTAAAACGACGGCCAGT CACAACTAACAATAACCAA 569-1335 60
PB2/BR GC AACAGCTATGACCATG CCTCAAGAGTTGATG
PB2/CF GC GTAAAACGACGGCCAGT GCAATAATTGTAGCC 1216-1874 45
PB2/CR GC AACAGCTATGACCATG ATTATTTGAGCAGTATC
PB2/DF GC GTAAAACGACGGCCAGT GAAGCCAATACAGCGGT 1793-2341 50
PB2/DR GC AACAGCTATGACCATG AGTAGAAACAAGG TCGTTTTTAAACAATTC
PB1/AF GC GTAAAACGACGGCCAGT AGCGAAAGCAGG CAAACCATTTGAATGG 1-719 50
PB1/AR GC AACAGCTATGACCATG CAGCGTCCTTGGTCATTG
PB1/BF GC GTAAAACGACGGCCAGT CTTCCAACGAAAGAGAA 577-1301 50
PB1/BR GC AACAGCTATGACCATG GGTTTAATATGGATACACC
PB1/CF GC GTAAAACGACGGCCAGT GCGGCTTCACTGAGTCCTGGC 1222-1863 50
PB1/CR GC AACAGCTATGACCATG CATTTTAAACAAACTTC
PB1/DF GC GTAAAACGACGGCCAGT CAAAGACTGGTCTACTG 1789-2341 50
PB1/DR GC AACAGCTATGACCATG AGTAGAAACAAGG CATTTTTTCATGAAGATC
PA/AF GC GTAAAACGACGGCCAGT AGCAAAAGCAGG TACTGATCCAAAATGG 1-615 50
PA/AR GC AACAGCTATGACCATG GCCTCTCTCGGACTGAC
PA/BF GC GTAAAACGACGGCCAGT GCCAGAATCAAGACCAGG 529-1255 50
PA/BR GC AACAGCTATGACCATG CTCACTTGGAATCCAACTTGC
PA/CF GC GTAAAACGACGGCCAGT GAGAGAAAGTGGATTTTGAGGATTG 1149-1785 50
PA/CR GC AACAGCTATGACCATG CTGAAGGAGGCAGCGCC
PA/DF GC GTAAAACGACGGCCAGT GACCCATGTTTTTGTATG 1700-2233 50
PA/DR GC AACAGCTATGACCATG AGTAGAAACAAGG TACTTTTTTGGACAG
HA/AF GC GTAAAACGACGGCCAGT AGCGAAAGCAGGGGACGATATT 1-515 50
HA/AR GC AACAGCTATGACCATG GATTTGTTAGCCAATTCAG
HA/BF GC GAAAACGACGGCCAGT CAGGTGTCACTCAAAAC G 428-1032 50
HA/BR GC AACAGCTATGACCATG GGATTTGCTTTTCTGGTAC
HA/CF GC GTAAAACGACGGCCAGT GGTTACATATGGAAAATGCC 939-1336 50
HA/CR GC AACAGCTATGACCATG GAGCCACCAGCAATTCT
HA/DF GC GTAAAACGACGGCCAGT GAAGGAAGAATTCAGGA 1251-1733 50
HA/DR GC AACAGCTATGACCATG GAGTAGAAACAAGGGTGTTTTTAAC
NP/AF GC GTAAAACGACGGCCAGT AGCGAAAGCAGGGTAGATAATC 1-570 50
NP/AR GC AACAGCTATGACCATG CCGTGGGAGGGTTGAGCC
NP/BF GC GTAAAACGACGGCCAGT GACACCACATACCAAAC 480-1075 45
NP/BR GC AACAGCTATGACCATG CTCTCAGGTCCTCAAAT
NP/CF GC GTAAAACGACGGCCAGT CCAGCACACAAGAGCCAG 1012-1569 55
NP/CR GC AACAGCTATGACCATG AGTAGAAACAAGGGTATTTTTC
NA/AF GC GTAAAACGACGGCCAGT AGCAAAAGCAGGAGTTT 1-508 45
NA/AR GC AACAGCTATGACCATG GCCCTATTTTGACACTC
NA/BF GC GTAAAACGACGGCCAGT CACACAGGGCTCATTAC 417-1049 45
NA/BR GC AACAGCTATGACCATG CCGAAACCTTTTACACCG
NA/CF GC GTAAAACGACGGCCAGT CACAGTTGGATATTTGTG 951-1461 50
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Table 1 Primer sequences and annealing temperatures used to sequence the genome of H3N8 EIV (Continued)
NA/CR GC AACAGCTATGACCATG AGTAGAAACAAGGAGTT
M/AF GC GTAAAACGACGGCCAGT AGCGAAAGCAGGTAGATATTTAAAG 1-654 50
M/AR GC AACAGCTATGACCATG CTAGCCTTACTAGCAAC
M/BF GC GTAAAACGACGGCCAGT CAGTACCACGGCTAAAG 571-1027 50
M/BR GC AACAGCTATGACCATG AGTAGAAACAAGGTAGTTTTTTAC
NS/AF GC GTAAAACGACGGCCAGT AGCGAAAGCAGGGTGACAAAAAC 1-492 50
NS/AR GC AACAGCTATGACCATG CTGCTCCTTCTTCGGTG
NS/BF GC GTAAAACGACGGCCAGT CATCATACTTAAAGCAAAC 407-890 50
NS/BR GC AACAGCTATGACCATG AGTAGAAACAAGGTAGTGTTTTTTAT
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substitution. In addition, a novel truncation in the re-
cently discovered PA-X gene was identified in A/equine/
Richmond/1/07, caused by an early stop codon at pos-
ition 20 of the +1 reading frame. The truncation of PA-
X by 42 amino acids has not been described before, with
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Figure 2 Agarose gel electrophoresis analysis of genome segment
C & D of segments 1–4 (PB2, PB1, PA and HA), A, B & C of segments 5 an
EIV Northamptonshire/1/13.(252 amino acids) or are truncated by 19 amino acids.
To investigate further and to study the evolution of the
truncation, the PA-X region of segment 3 from an add-
itional 29 EIV isolated in the UK between 2005 and
2013, including 9 from 2007, were sequenced using the
method described here (see Additional file 3). The 42
amino acid truncation in A/equine/Richmond/1/07 PA-C D A B C D





PCR products. Agarose gel (1%) showing PCR fragments A, B,
d 6 (NP and NA), and A & B of segments 7 and 8 (M and NS) of
Table 2 Nucleotide and amino acid differences between A/equine/Richmond/1/07 and A/equine/Lincolnshire/1/07
Segment Nucleotide changes Protein Amino acid changes Amino acid changes from Richmond/1/07 to Lincolnshire/1/07
1 35 PB2 4 A105T, K251R, I398V, K660R
2 48 PB1 8 F94L, M119V, V149I, M179I, R329Q, E377D,D618E, K621R
3 47 PA 13 D64E, I86M, M210A, K237E, G240E, P259S, N321S, L348I, S409N, I465V,
T476A, I500V, R626K
4 47a HA1† 11b K-14T, F-11L, I-9a1, F-9b1, N7G, R62K, V78A, D104N, A138S, N159S, E291D
HA2 3 T43A, E50G, I198V
5 30 NP 4 I131M, T257I, A359T, S450N
6 37 NA‡ 12 T9A, S12F, V35A, E40K, G42D, H66Y, P78S, I191V, N235D, S337N, I410V,
G416E
7 24 M1 3 I15V, I80V, K95R
M2 2 S86D, 290G
8 11 NS1 4 I48S, I84V, Y207H, G210R
NS2/NEP 1 M52I
aIncludes a 6 nucleotide duplication resulting in btwo additional amino acids in A/equine/Richmond/1/07. †Numbering starting after the putative signal sequence,
‡numbering starting from start codon 1Two amino acid insertion in Richmond/1/07 HA, not present in Lincolnshire/1/07.
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other horse in the same outbreak that A/equine/Rich-
mond/1/07 was isolated from, and the other two from a
separate outbreak in 2007. The remaining isolates did
not share the truncation, and all had a full length PA-X
of 252 amino acids (61 amino acids following the +1
frameshift) (see Additional file 3).
Sequencing of the non-coding regions of equine influenza
viruses
Previous studies have shown that there are discrepancies
in the segments that contain a cytosine at nucleotide
position four of the 3′ NCR, and that a cytosine at this
position is not restricted to the polymerase segments
[23]. This variation has been implicated in the differing
levels of vRNA and mRNA synthesis observed during
the virus replication cycle whereby a uracil at this pos-
ition increased mRNA production and delayed vRNA
synthesis [23]. Another study showed that the fourth nu-
cleotide of the NCR at the 3′ end of influenza vRNA
segments could influence rescue of viruses using reverse
genetics [19]. As one of our future aims was to generate
a reverse genetics system for A/equine/Richmond/1/07,
we determined the sequence of the NCRs for each vRNA
segment for this virus strain. Viral RNA was self-ligated,
then each of the NCRs amplified using a universal
primer complementary to the opposite NCR and a seg-
ment specific primer, as described by de Wit et al. [20].
Modifications were made to all but two of the published
primer sequences to ensure that they were complemen-
tary to equine influenza viruses sequenced previously
(Table 3). The NCRs from each segment were amplified
successfully, but with varying degrees of efficiency. In
particular the 3′ of segment 8 was amplified to a high
level, whereas products of the correct size for the 5′ ofsegment 6, and both the 5′ and 3′ of segment 7 were
not visible by gel electrophoresis, as shown in Figure 3.
Despite bands of the correct size not being visible for
these products, sequence covering the NCR regions of
interest were successfully determined for all three. Sub-
sequent sequencing of the amplified NCRs revealed that
the 13 nucleotides of the 5′ end were identical in all 8
viral gene segments, as well as the 12 bases of the 3′
end of the vRNA except for the fourth nucleotide. The
three polymerase segments (PB2, PB1 and PA) all con-
tained a cytosine, whilst the remaining segments (HA,
NP, NA, M and NS) contained a uracil at the fourth nu-
cleotide position.
Discussion
We and others have previously shown that reassortment
has occurred between different EIV [4-8,15,16], but a
lack of full genome sequences for EIV makes it difficult
to ascertain the extent of reassortment between them,
and whether reassortment has occurred between EIV
and influenza A viruses from other species. We therefore
developed a simple method for sequencing viral ge-
nomes that included primers with M13 sequence tags to
improve the sequencing efficiency. This was based upon
the approach recommended by the WHO for sequen-
cing swine influenza virus isolates in 2009 [21], however
our method used only 26 PCR fragments to cover the
segment-specific regions of EIV, rather than 46 frag-
ments. Alternative methods have been employed for
sequencing influenza A viruses, such as using universal
primers to simultaneously amplify all eight genome seg-
ments, or segment specific primers to amplify entire seg-
ments; however, in our hands such protocols result in
poor amplification of the three largest genome segments
(data not shown). Other methods based on amplification
Table 3 Primer sequences used for sequencing 3′ and 5′




















†Sequences from de Wit et al., [20] shown in italics with specific individual
nucleotide changes in bold text, plus novel primer sequences for the N8
NA segment.
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quences in the primers, which makes the method de-
scribed here simple and efficient. A method previously
described for sequencing the NCRs of the influenza gene
segments was also modified and successfully used for
the first time on an equine influenza virus, with novel
primers designed for an N8 subtype NA.
The two segments encoding the surface glycoproteins,
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Figure 3 Agarose gel electrophoresis analysis of non-coding region P
non-coding regions of A/equine/Richmond/1/07 influenza virus gene segm
black arrows. Bands of the expected size were visible in all lanes except fordifferences between the two viruses. This was expected
as these two proteins are under constant immune-driven
selection pressure to undergo antigenic drift. Interest-
ingly a high number of amino acid differences were
found in PA, especially when compared to the other two
polymerase subunits PB2 and PB1, and a similar finding
was observed by Murcia et al. [5]. The other internal
segments contained fewer changes, which is not surpris-
ing as they are both smaller and may be under less im-
mune pressure than the surface proteins.
Interestingly, a mutation in the +1 reading frame of
PA, causing a premature stop codon in the translated
amino acid sequence of PA-X, was observed in A/
equine/Richmond/1/07. PA-X is a recently discovered
protein containing the N-terminal 191 amino acids of
PA and, in the majority of strains, a further 61 amino
acids derived from a frameshift to the +1 reading frame
of PA [24]. PA-X has been implicated in the modulation
of influenza virus pathogenicity and virulence in a
mouse model, whereby PA-X deficient viruses caused
greater clinical signs and were less able to shut off host
cell responses compared to wild-type viruses with full
length PA-X [24]. The premature stop codon in A/
equine/Richmond/1/07 would lead to a truncation of the
protein by 42 amino acids. Truncated forms of PA-X
have been described previously, however the majority of
these are due to a nonsense mutation at codon 42 in
the +1 reading frame [25]. Sequencing of PA, as de-
scribed here, revealed that several other virus isolates
from different outbreaks in 2007 as well as from the
same yard as A/equine/Richmond/1/07, had the same
truncated form of PA-X, however the truncated form did
not persist in the UK.
Sequence analysis of the NCRs from each segment
showed that EIV strain A/equine/Richmond 1/07 had




3’ 3’ 3’ 3’5’ 5’ 5’ 5’
Seg. 5 (NP) Seg. 6 (NA) Seg. 7 (M) Seg. 8 (NS)
CR products. Agarose gel (2.5%) showing PCR fragments for the
ents. The positions of molecular weight markers are indicated by
NA 5′, M 3′ and 5′.
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and uracil at this position in the remaining 5 segments.
This is the same pattern seen in the majority of other influ-
enza A viruses for which the promoter sequences have been
determined, including the prototype avian influenza virus,
A/chicken/Rostock/34 (H7N1) [26].
The methods outlined here can be used to determine
the genome sequences of EIV, including the NCRs, from
both clade 1 and clade 2 of the Florida sublineage. The
techniques described here are affordable, and the equip-
ment required is available in most research laboratories.
The sequence assembly process is simple and does not
require in depth bioinformatics, unlike next generation
sequencing methodology. Due to the small genome size
and small sample numbers usually associated with EIV, this
method is therefore highly cost effective and straightfor-
ward. Amplicon sequencing has also been shown to be less
labour intensive and more affordable than plasmid cloning
methods [27]. This method also permits the sequencing of
individual gene segments with relative ease, as was the case
with PA described here to investigate the frequency of the
truncated form of PA-X.
Conclusions
We have developed a simple, efficient and affordable
method for sequencing whole genomes of EIV that of-
fers an improvement compared with previously pub-
lished methods. The adoption of these methods should
facilitate an increase in the number of full genome se-
quences available for EIV. This will benefit surveillance
programmes for EIV and improve understanding of the




EIV A/equine/Richmond/1/07 and A/equine/Lincolnshire/
1/07 had previously been isolated and passaged twice
in embryonated chicken eggs [4]. RNA was isolated
from 140 μl virus stocks containing ~107 EID50/ml
using a QIAamp Viral RNA Mini Kit (Qiagen), accord-
ing to manufacturer’s directions. RNA was eluted in
50 μl elution buffer.
cDNA synthesis
Using a UNI-12 primer, as described by Hoffmann et al.
[28], cDNA was transcribed by denaturing 2 μl RNA in
the presence of UNI-12 (1 μM final concentration) and
7 μl water at 70°C for 10 minutes and then cooling on
ice. Following this, dNTP mix (final concentration each
0.5 μM), 1 × First Strand buffer, 200U Superscript II
reverse transcriptase (Invitrogen) and water to a final
volume of 20 μl were added. The reaction mixture was
incubated at 42°C for 45 minutes.PCR amplification of gene segments
Viral gene segments were amplified in 50 μl PCR reac-
tions consisting of 2 μl cDNA (representing 10% of the
reverse transcription reaction), dNTP mix (0.2 mM each
final concentration) (Qiagen), 1 × Pfu buffer, 2.5U Native
Pfu DNA polymerase (Stratagene), water and oligonucleo-
tide pairs (final concentration each of 0.2 μM) as listed in
Table 1. The cycling conditions were as follows: initial
denaturation at 96°C for 1 minute, followed by 25 cycles of
denaturation at 96°C for 15 seconds, primer annealing at
50-60°C (see Table 1) for 10 seconds and elongation at 60°C
for 5 minutes. PCR reactions were analysed on a 1% agar-
ose gel containing GelRed nucleic acid stain (Biotium)
according to manufacturer’s directions. PCR products were
purified using a QIAquick PCR purification kit (Qiagen) ac-
cording to manufacturer’s directions.PCR amplification of non-coding regions
The method described by de Wit et al. [20] was used
with modifications, as detailed in Table 2. Novel primers
were designed to amplify the N8 subtype NA segment.
Briefly, following an initial denaturation at 65°C for 5 mi-
nutes in the presence of T4 RNA ligase buffer and 20U
RNAsin RNase inhibitor (Promega), 15 μl RNA was li-
gated using 40U T4 RNA ligase (New England Biolabs)
at 37°C for 1 hour. The ligation reaction was stopped by
heat inactivation at 65°C for 10 minutes. cDNA was
transcribed from 4 μl of the ligated RNA by incubating
the RNA in a mixture consisting of 0.5 μg random pri-
mer (Promega), dNTP mix (0.5 mM each final concen-
tration) (Qiagen) and 20U RNasin at 65°C for 5 minutes,
then cooling to 4°C, before adding 20U RNasin, 5 mM
DTT, 200U Superscript II (Invitrogen) and 1 × First
Strand buffer in a total reaction volume of 20 μl. The re-
action mixture was subsequently incubated at 25°C for
5 minutes, followed by 50°C for 1 hour. 50 μl PCR reac-
tions consisting of 4 μl cDNA (representing 20% of the
reverse transcription reaction), dNTP mix (20 mM final
concentration), universal primer (3′- or 5′- final concen-
tration 0.2 μM) (Table 2), gene segment specific primer
(3′- or 5′- final concentration 0.2 μM) (Table 2), 1 × Pfu
buffer and 2.5U Native Pfu DNA polymerase (Strata-
gene) were made. The cycling conditions were as fol-
lows: initial denaturation at 96°C for 6 minutes, followed
by 40 cycles of denaturation at 96°C for 30 seconds, pri-
mer annealing at 37°C for 1 minute and elongation at
72°C for 2 minutes. PCR reactions were analysed on a
2.5% agarose gel containing GelRed nucleic acid stain
(Biotium) according to manufacturer’s directions. PCR
products were purified using a QIAquick PCR purifica-
tion kit (Qiagen) according to manufacturer’s directions.
Where multiple bands were present in the gel, bands
of the correct size were excised and purified using a
Rash et al. Virology Journal 2014, 11:159 Page 9 of 9
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Sequencing
Sequencing reactions were performed using the BigDye
terminator sequencing kit version 3.1 (Applied Biosys-
tems). M13 forward and reverse primers were used for
gene segment PCR products, whilst for the non-coding
regions the primers used for the PCR stage were reused,
both at a final concentration of 80nM. The sequencing
reactions were run on a 3130xl genetic analyzer (Applied
Biosystems), and the resulting nucleotide sequences were
visualised, assembled and edited using SeqMan II ver-
sion 5.03 (DNAStar, Inc) and BioEdit version 7.0.5.3 (Ibis
Pharmaceuticals Inc.).
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Additional file 1: GISAID EpiFlu database [19] accession numbers
for PA-X sequences.
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database [19] accession numbers for other strains.
Additional file 3: Alignment of predicted amino acid sequences for
PA-X from EIV isolated in the UK between 2005 and 2013. Amino
acids of the C-terminal PA-X domain only, following the +1 frameshift,
are shown.
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